Google’s two-qubit strategy: What the neutral atom expansion means for IonQ, QuEra, and the future of quantum computing
Can Oracle (NYSE: ORCL) turn enterprise AI from demo theater into operational software that actually runs the business?
Read More 4 minute read Pharma Industry News Ensho Therapeutics unveils new data on NSHO-101 as once-daily treatment for inflammatory bowel disease Ensho Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing oral therapies for inflammatory diseases, has presented promising… byPallavi MadhirajuFebruary 23, 2025